The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer

被引:5
作者
Liu, Xiao-Ping [1 ]
Yin, Xiao-Hong [1 ]
Yan, Xin-Hui [2 ]
Zeng, Xian-Tao [1 ,3 ]
Wang, Xing-Huan [3 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Ctr Evidence Based & Translat Med, Wuhan, Hubei, Peoples R China
[2] Lanzhou Univ, Dept Cardiol, Hosp 1, Lanzhou, Gansu, Peoples R China
[3] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Hubei, Peoples R China
来源
MEDICAL SCIENCE MONITOR | 2018年 / 24卷
关键词
Gene Expression; Prognosis; Urinary Bladder Calculi; URINARY-BLADDER; EXPRESSION; PROGRESSION; CARCINOMA;
D O I
10.12659/MSM.906721
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The present study aimed to investigate the clinical relevance of fragile histidine triad protein (FHIT) in patients with bladder cancer (BC). Material/Methods: Three independent BC microarray studies were collected and reanalyzed. The expression of FHIT was evaluated between BC samples and normal bladder tissues. The correlation between the expression of FHIT and clinicopathological features was analyzed using the chi-square test. Log-rank based survival analysis was conducted to detect the survival significance of FHIT in patients with BC Gene set enrichment analysis (GSEA) was performed to identify the mechanisms. Results: FHIT was significantly downregulated in BC cells (p=0.0044). BC patients in the FHIT high expression group had better clinical characteristics (including invasiveness, tumor grade, disease progression, and T staging) than those in the FHIT low expression group (p<0.0001, p<0.0001, p=0.031, p<0.0001, and p=0.056, respectively). Patients in the FHIT high expression group had better cancer-specific survival (p<0.0001) and overall survival (p=0.0008) than those in the FHIT low expression. GSEA results indicated that BC samples in the FHIT low expression group were enriched in interferon alpha response, apoptosis, androgen response, interferon gamma response, heme metabolism, and transforming growth factor (TGF) beta signaling. Conclusions: FHIT predicts better clinical relevance for patients with BC, which may be a promising therapeutic target.
引用
收藏
页码:3113 / 3118
页数:6
相关论文
共 50 条
  • [41] Clinical relevance of circulating tumor cells in cancer patients
    Hamilton G.
    memo - Magazine of European Medical Oncology, 2015, 8 (4) : 227 - 230
  • [42] Clinical value of PTEN in patients with superficial bladder cancer
    Han, Kyung Seok
    Jeong, In Gab
    Joung, Jae Young
    Yang, Seung Ok
    Chung, Jinsoo
    Seo, Ho Kyung
    Kwon, Kyung Suk
    Park, Weon Seo
    Lee, Kang Hyun
    UROLOGIA INTERNATIONALIS, 2008, 80 (03) : 264 - 269
  • [43] FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer
    Czarnecka, Karolina H.
    Migdalska-Sek, Monika
    Domanska, Daria
    Pastuszak-Lewandoska, Dorota
    Dutkowska, Agata
    Kordiak, Jacek
    Nawrot, Ewa
    Kiszalkiewicz, Justyna
    Antczak, Adam
    Brzezianska-Lasota, Ewa
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1175 - 1184
  • [44] Biological and Clinical Significance of GATA3 Detected from TCGA Database and FFPE Sample in Bladder Cancer Patients
    Wang, Chenglu
    Yang, Shuang
    Jin, Lu
    Dai, Guangcheng
    Yao, Qiu
    Xiang, Han
    Zhang, Yongsheng
    Liu, Xiaolong
    Xue, Boxin
    ONCOTARGETS AND THERAPY, 2020, 13 : 945 - 958
  • [45] Clinical Findings on Fibroblast Activation Protein in Patients with Gastric Cancer
    Fukumoto, Youji
    Yamada, Yoshinori
    Fukuda, Kenji
    Saito, Hiroaki
    Tatebe, Shigeru
    Tsujitani, Shunichi
    Ikeguchi, Masahide
    YONAGO ACTA MEDICA, 2009, 52 (01) : 21 - 25
  • [46] Association of thymosin β4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients
    Wang, Z. Y.
    Zhang, W.
    Yang, J. J.
    Song, D. K.
    Wei, J. X.
    Gao, S.
    NEOPLASMA, 2016, 63 (06) : 991 - 998
  • [47] Clinical and molecular response to alpha1-oleate treatment in patients with bladder cancer
    Haq, Farhan
    Sabari, Samudra
    Hacek, Jaromir
    Brisuda, Antonin
    Ambite, Ines
    Cavalera, Michele
    Esmaeili, Parisa
    Wan, Murphy Lam Yim
    Ahmadi, Shahram
    Babjuk, Marek
    Svanborg, Catharina
    CANCER MEDICINE, 2024, 13 (17):
  • [48] Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients
    Hu, Li
    Sun, Jie
    Li, Zhongwu
    Qu, Ziwei
    Liu, Yan
    Wan, Qiting
    Liu, Jiaming
    Ding, Xinyun
    Zang, Fan
    Zhang, Juan
    Yao, Lu
    Xu, Ye
    Wang, Yin
    Xie, Yuntao
    NPJ BREAST CANCER, 2022, 8 (01)
  • [49] SKIP expression is correlated with clinical prognosis in patients with bladder cancer
    Wang, Longwang
    Zhang, Mei
    Wu, Yong
    Cheng, Cheng
    Huang, Yawei
    Shi, Zimin
    Huang, Hongwei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (04): : 1695 - 1701
  • [50] Pilot Study of the Clinical Significance of Serum and Urinary HER-2/neu Protein in Bladder Cancer Patients
    Kim, Taek Sang
    Rhew, Hyun Yul
    Hwang, Hyun Yong
    KOREAN JOURNAL OF UROLOGY, 2011, 52 (12) : 815 - 818